Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2007
11/28/2007EP1858873A2 Process for the purification of duloxetine hydrochloride
11/28/2007EP1858859A1 Process for the preparation of optically active (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine
11/28/2007EP1858504A1 Carnitine-containing peritoneal dialysis solution having improved biocompatibility
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007CN101080404A Pyrimidinylisoxazol derivative
11/28/2007CN101077402A Traditional Chinese medicine compound for treating prostate gland disease and preparation method and application thereof
11/28/2007CN101077376A Traditional Chinese medicine decoction
11/28/2007CN101077338A Nano lanthanum carbonate and orally disintegrating tablet and preparation method
11/28/2007CN101077212A Multi-flavor vision-improving beverage
11/28/2007CN101077187A Medicinal diet for facial-nourishing kidney-nourishing and yang-strengthening food
11/28/2007CN101077113A Se-enriched cordyceps militaris tea and its preparing process
11/28/2007CN100351255C Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351237C Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
11/28/2007CN100350973C Drug composition for curing disease produced from IL-6
11/28/2007CN100350919C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
11/28/2007CN100350916C Extraction process of effective component for compound Chinese medicine composition of asiaticoside
11/27/2007US7300950 Pyrazole derivatives, their preparation and their use in pharmaceuticals
11/27/2007US7300935 Gonadotropin-releasing hormone antagonistic activity, therapy of prostatic cancer, endometriosis, precocious puberty; N-(4-(1-(2,6-difluorobenzyl)-5-(((2-ethoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea
11/27/2007US7300925 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3
11/27/2007US7300917 Remedy for chronic disease
11/27/2007US7300652 Contacting cell expressing kidney injury-molecule-1 (KIM-1) cell surface polypeptide with an effective amount of an isolated antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide
11/27/2007CA2379695C Compounds for modulating the rage receptor
11/27/2007CA2340728C Methods of treating hypertension and compositions for use therein
11/27/2007CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132893A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor
11/22/2007WO2007132841A1 Fused heterocyclic compound and use thereof
11/22/2007WO2007131767A2 Novel actives against prostate carcinoma
11/22/2007WO2007093183A3 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/22/2007WO2000018212A8 Platelet-derived growth factor c, dna coding therefor, and uses thereof
11/22/2007US20070270506 Novel human kinases and polynucleotides encoding the same, and uses thereof
11/22/2007US20070270495 Use of Cystine or Cysteine for the Prevention and Treatment of Oxidative Stress Cause by Haemodialysis and of Acute or Chronic Kidney Diseases
11/22/2007US20070270490 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
11/22/2007US20070270459 Overactive bladder treating drug
11/22/2007US20070270439 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070269538 Method for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs
11/22/2007US20070269484 Drug-delivery stent formulations for restenosis and vulnerable plaque
11/21/2007EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007EP1857455A1 Cinnamoyl compound and use thereof
11/21/2007EP1857445A2 Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1856041A1 Crystallisation and purification of glycopyrronium bromide
11/21/2007EP1855675A1 Use of a pyrazole derivative for preparing medicines useful for preventing or treating renal diseases
11/21/2007EP1613584B1 Pharmaceutical formulations comprising highly pure bases of 3,3-diphenyl propylamine monoesters
11/21/2007EP1482920B1 Compositions containing n-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
11/21/2007EP1474140B1 2-oxazolamines and their use as 5-ht2b receptor antagonists
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007CN101076521A Process for producing muscarine receptor antagonist and intermediate therefor
11/21/2007CN101073661A Medicine for treating nephropathy and its production
11/21/2007CN101073659A Chinese-herb-medicinal oral preparation for treating lithangiuria and cholecystolithiasis
11/21/2007CN101073658A Paste for treating prostate
11/21/2007CN101073617A Use of medicinal composition in treatment of micro-circulation handicap and prevention of stroke
11/21/2007CN101073577A Use of asiaticoside
11/21/2007CN101073443A Pants for treating prostatitis
11/21/2007CN101073442A Slow-releasing fiber underwear
11/21/2007CN101073349A Tea with body-strengthening and lung-invigorating functions
11/21/2007CN100349881C New substituted penta azacyclo salt kind compound and its use in treating protein ageing related disease
11/21/2007CN100349586C Chinese medicine for treating nephroma and its use
11/21/2007CN100349583C Chinese traditional medicine for treating chronic nephritis
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297763 Mixture of IGF-1 and N,N-bis(3-D-gluconamidopropyl)-deoxycholamine that binds specifically to IGF-1 and blocks binding of IGFBP-1 and IGFBP-3; used as a standard for identifying IGF-1 indirect agonists
11/20/2007US7297698 e.g. (2R,5S)-4-(3-chloro-4-cyanophenyl)-N-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide; antiandrogenic agent
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297684 breast and prostatic tumors; administration of an antisense oligodeoxynucleotide which is complementary to a portion of the gene encoding insulin-like growth factor binding protein -5
11/20/2007US7297681 For use in therapy of growth metabolic disorders
11/15/2007WO2007130589A2 Nl, n4-bis (buta-i, 3-dienyl) butane-i, 4-diamine pharmaceutical compositions and uses thereof
11/15/2007WO2007129618A1 Inhibitor of neutrophil activation/migration factor and use thereof
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007128482A1 Use of a b-cell-depleting antibody for treatment of polyoma virus infections
11/15/2007WO2007128462A1 Potassium channel activators for the prevention and treatment of dystonia and dystonia-like symptoms
11/15/2007WO2006138537A3 Ex vivo blood treatment with renal epithelial cells in cardiorenal and hepatorenal syndrome
11/15/2007WO2006086456A3 Combination of organic compounds
11/15/2007US20070265323 Compounds for the treatment of metabolic disorders
11/15/2007US20070265322 Compounds for the treatment of metabolic disorders
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265283 Xanthine Oxidase Inhibitor
11/15/2007US20070265280 Methods of using sodium channel blockers
11/15/2007US20070265228 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis
11/15/2007US20070265188 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
11/15/2007US20070264333 Method of treatment
11/15/2007US20070264309 Method Of Treating Atrophic Vaginitis
11/15/2007US20070264267 Nucleotide sequences coding zinc transport protein for use in diagnosis, prevention and treatment of cell proliferative disorders
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007US20070264195 Modulation of Activity of Neurotrophins
11/15/2007CA2650926A1 N1,n4-bis(buta-1,3-dienyl)butane-1,4-diamine pharmaceutical compositions and methods thereof
11/15/2007CA2650853A1 Potassium channel activators for the prevention and treatment of dystonia and dystonia-like symptoms
11/14/2007EP1854808A2 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/14/2007EP1854777A1 Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same
11/14/2007EP1854476A2 Use of relaxin to treat diseases related to vasoconstriction
11/14/2007EP1854454A2 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
11/14/2007EP1853593A1 Crystalline and amorphous 4-cyano-n{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride
11/14/2007EP1853564A1 Novel quinoline derivatives as potassium ion channel openers
11/14/2007EP1853266A1 Methods and compositions for treating diabetes, metabolic syndrome and other conditions
1 ... 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 ... 562